Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
AOD 9604 does not raise blood sugar, does not cause insulin resistance, and does not interfere with tirzepatide insulin-sensitizing effects
Comparison Table (Structure, Pathway, Research Classification) Each compounds classification reflects its underlying mechanism rather than a shared fat-loss peptide category: AOD-9604 remains research-stage and inconclusive, GLP-1 S has the most extensive clinical backing of the three, and tesamorelin occupies a narrower but well-documented niche in visceral fat and GH-axis research
Split dosing may help if: single morning dose produces effects that fade by afternoon, you are using higher doses (450-500mcg) where sustained levels may help, or evening administration fits your schedule better than early morning
A high vitamin B12 blood level is possible
Learn how to create customized meal plans by becoming a certified nutritionist
How much are B12 injections
